The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: lactulose     Quarter: 2016Q3

Total Drug/Injury Combinations: 134     Number of Pages: 7

DRUGNAME PT EventCount
LACTULOSE. Skin cancer 3 view events
LACTULOSE. Skin wound 3 view events
LACTULOSE. Vomiting 3 view events
LACTULOSE. Vomiting projectile 3 view events
LACTULOSE ORAL SOLUTION Asthenia 2 view events
LACTULOSE ORAL SOLUTION Condition aggravated 2 view events
LACTULOSE ORAL SOLUTION Constipation 2 view events
LACTULOSE ORAL SOLUTION Lethargy 2 view events
LACTULOSE ORAL SOLUTION Off label use 2 view events
LACTULOSE ORAL SOLUTION Swollen tongue 2 view events
LACTULOSE ORAL SOLUTION Underdose 2 view events
LACTULOSE ORAL SOLUTION Vomiting 2 view events
LACTULOSE ORAL SOLUTION Weight increased 2 view events
Lactulose Solution,USP Confusional state 2 view events
LACTULOSE. Balance disorder 2 view events
LACTULOSE. Blood count abnormal 2 view events
LACTULOSE. Blood sodium decreased 2 view events
LACTULOSE. Change of bowel habit 2 view events
LACTULOSE. Cognitive disorder 2 view events
LACTULOSE. Confusional state 2 view events

Total Drug/Injury Combinations: 134     Number of Pages: 7

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)